Farther Finance Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.3M | Buy |
23,495
+5,670
| +32% | +$4.42M | 0.37% | 47 |
|
2025
Q1 | $14.4M | Buy |
17,825
+3,700
| +26% | +$2.98M | 0.37% | 51 |
|
2024
Q4 | $10.9M | Buy |
14,125
+152
| +1% | +$117K | 0.39% | 52 |
|
2024
Q3 | $12.4M | Buy |
13,973
+1,520
| +12% | +$1.35M | 0.46% | 36 |
|
2024
Q2 | $11.4M | Buy |
12,453
+4,157
| +50% | +$3.8M | 0.55% | 32 |
|
2024
Q1 | $6.31M | Buy |
8,296
+652
| +9% | +$496K | 0.38% | 50 |
|
2023
Q4 | $4.46M | Buy |
7,644
+2,350
| +44% | +$1.37M | 0.32% | 63 |
|
2023
Q3 | $2.84M | Buy |
5,294
+1,743
| +49% | +$936K | 0.45% | 42 |
|
2023
Q2 | $1.67M | Buy |
3,551
+2,819
| +385% | +$1.32M | 0.36% | 56 |
|
2023
Q1 | $251K | Sell |
732
-50
| -6% | -$17.2K | 0.07% | 235 |
|
2022
Q4 | $286K | Buy |
+782
| New | +$286K | 0.11% | 181 |
|